nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—ALB—chronic obstructive pulmonary disease	0.579	1	CbGaD
Magnesium salicylate—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.181	0.707	CbGbCtD
Magnesium salicylate—ALB—Prednisone—chronic obstructive pulmonary disease	0.0751	0.293	CbGbCtD
Magnesium salicylate—Intoxication—Aminophylline—chronic obstructive pulmonary disease	0.00838	0.0637	CcSEcCtD
Magnesium salicylate—Poisoning—Aminophylline—chronic obstructive pulmonary disease	0.00838	0.0637	CcSEcCtD
Magnesium salicylate—Epigastric pain—Aminophylline—chronic obstructive pulmonary disease	0.00467	0.0355	CcSEcCtD
Magnesium salicylate—Epigastric pain—Salbutamol—chronic obstructive pulmonary disease	0.00335	0.0255	CcSEcCtD
Magnesium salicylate—Heartburn—Aminophylline—chronic obstructive pulmonary disease	0.00328	0.0249	CcSEcCtD
Magnesium salicylate—Pulmonary function test decreased—Aminophylline—chronic obstructive pulmonary disease	0.003	0.0228	CcSEcCtD
Magnesium salicylate—Respiratory depression—Aminophylline—chronic obstructive pulmonary disease	0.003	0.0228	CcSEcCtD
Magnesium salicylate—Heartburn—Salbutamol—chronic obstructive pulmonary disease	0.00236	0.0179	CcSEcCtD
Magnesium salicylate—PTGS1—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00224	0.0724	CbGpPWpGaD
Magnesium salicylate—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.00215	0.0164	CcSEcCtD
Magnesium salicylate—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.00202	0.0153	CcSEcCtD
Magnesium salicylate—PTGS2—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00178	0.0575	CbGpPWpGaD
Magnesium salicylate—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.0015	0.0114	CcSEcCtD
Magnesium salicylate—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.011	CcSEcCtD
Magnesium salicylate—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00145	0.011	CcSEcCtD
Magnesium salicylate—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.00873	CcSEcCtD
Magnesium salicylate—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.00112	0.00853	CcSEcCtD
Magnesium salicylate—Asthma—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00819	CcSEcCtD
Magnesium salicylate—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00819	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00817	CcSEcCtD
Magnesium salicylate—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.00808	CcSEcCtD
Magnesium salicylate—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00802	CcSEcCtD
Magnesium salicylate—Ketoprofen—CXCL8—chronic obstructive pulmonary disease	0.00105	0.418	CrCbGaD
Magnesium salicylate—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00799	CcSEcCtD
Magnesium salicylate—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.00798	CcSEcCtD
Magnesium salicylate—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.00785	CcSEcCtD
Magnesium salicylate—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00773	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000995	0.00756	CcSEcCtD
Magnesium salicylate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000959	0.00729	CcSEcCtD
Magnesium salicylate—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000941	0.00715	CcSEcCtD
Magnesium salicylate—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000907	0.0069	CcSEcCtD
Magnesium salicylate—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000887	0.00675	CcSEcCtD
Magnesium salicylate—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00087	0.00661	CcSEcCtD
Magnesium salicylate—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000856	0.0065	CcSEcCtD
Magnesium salicylate—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000845	0.00642	CcSEcCtD
Magnesium salicylate—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.000841	0.00639	CcSEcCtD
Magnesium salicylate—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00084	0.00639	CcSEcCtD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.000836	0.027	CbGpPWpGaD
Magnesium salicylate—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000826	0.00628	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000799	0.00607	CcSEcCtD
Magnesium salicylate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000798	0.00607	CcSEcCtD
Magnesium salicylate—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000792	0.00602	CcSEcCtD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00078	0.0252	CbGpPWpGaD
Magnesium salicylate—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000768	0.00583	CcSEcCtD
Magnesium salicylate—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000767	0.00583	CcSEcCtD
Magnesium salicylate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000761	0.00579	CcSEcCtD
Magnesium salicylate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00076	0.00578	CcSEcCtD
Magnesium salicylate—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000759	0.00577	CcSEcCtD
Magnesium salicylate—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000759	0.00577	CcSEcCtD
Magnesium salicylate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000756	0.00575	CcSEcCtD
Magnesium salicylate—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000756	0.00574	CcSEcCtD
Magnesium salicylate—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000752	0.00572	CcSEcCtD
Magnesium salicylate—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000747	0.00568	CcSEcCtD
Magnesium salicylate—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000735	0.00559	CcSEcCtD
Magnesium salicylate—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000735	0.00559	CcSEcCtD
Magnesium salicylate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000717	0.00545	CcSEcCtD
Magnesium salicylate—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000709	0.00539	CcSEcCtD
Magnesium salicylate—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.0007	0.00532	CcSEcCtD
Magnesium salicylate—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000694	0.00528	CcSEcCtD
Magnesium salicylate—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000668	0.00508	CcSEcCtD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.000663	0.0215	CbGpPWpGaD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.000655	0.0212	CbGpPWpGaD
Magnesium salicylate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000649	0.00493	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000645	0.0049	CcSEcCtD
Magnesium salicylate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000639	0.00486	CcSEcCtD
Magnesium salicylate—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000618	0.00469	CcSEcCtD
Magnesium salicylate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000613	0.00466	CcSEcCtD
Magnesium salicylate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000613	0.00466	CcSEcCtD
Magnesium salicylate—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000611	0.00464	CcSEcCtD
Magnesium salicylate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000603	0.00458	CcSEcCtD
Magnesium salicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.000603	0.0195	CbGpPWpGaD
Magnesium salicylate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.0006	0.00456	CcSEcCtD
Magnesium salicylate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000578	0.0044	CcSEcCtD
Magnesium salicylate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000572	0.00435	CcSEcCtD
Magnesium salicylate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000572	0.00435	CcSEcCtD
Magnesium salicylate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00057	0.00433	CcSEcCtD
Magnesium salicylate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.00433	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000559	0.00425	CcSEcCtD
Magnesium salicylate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000551	0.00419	CcSEcCtD
Magnesium salicylate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000551	0.00419	CcSEcCtD
Magnesium salicylate—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000547	0.0177	CbGpPWpGaD
Magnesium salicylate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000545	0.00414	CcSEcCtD
Magnesium salicylate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000545	0.00414	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000544	0.0176	CbGpPWpGaD
Magnesium salicylate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000541	0.00411	CcSEcCtD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.000541	0.0175	CbGpPWpGaD
Magnesium salicylate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000539	0.0041	CcSEcCtD
Magnesium salicylate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000539	0.0041	CcSEcCtD
Magnesium salicylate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000537	0.00408	CcSEcCtD
Magnesium salicylate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000533	0.00406	CcSEcCtD
Magnesium salicylate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000532	0.00405	CcSEcCtD
Magnesium salicylate—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000531	0.00404	CcSEcCtD
Magnesium salicylate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000528	0.00402	CcSEcCtD
Magnesium salicylate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000524	0.00398	CcSEcCtD
Magnesium salicylate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000524	0.00398	CcSEcCtD
Magnesium salicylate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000524	0.00398	CcSEcCtD
Magnesium salicylate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000524	0.00398	CcSEcCtD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.00052	0.0168	CbGpPWpGaD
Magnesium salicylate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000514	0.00391	CcSEcCtD
Magnesium salicylate—Pain—Montelukast—chronic obstructive pulmonary disease	0.000513	0.0039	CcSEcCtD
Magnesium salicylate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000512	0.00389	CcSEcCtD
Magnesium salicylate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000509	0.00387	CcSEcCtD
Magnesium salicylate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000508	0.00386	CcSEcCtD
Magnesium salicylate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000507	0.00385	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000505	0.00384	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000505	0.00384	CcSEcCtD
Magnesium salicylate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000504	0.00383	CcSEcCtD
Magnesium salicylate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000503	0.00382	CcSEcCtD
Magnesium salicylate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000502	0.00382	CcSEcCtD
Magnesium salicylate—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000501	0.00381	CcSEcCtD
Magnesium salicylate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000495	0.00376	CcSEcCtD
Magnesium salicylate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000495	0.00376	CcSEcCtD
Magnesium salicylate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000487	0.0037	CcSEcCtD
Magnesium salicylate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000487	0.0037	CcSEcCtD
Magnesium salicylate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000483	0.00367	CcSEcCtD
Magnesium salicylate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000479	0.00364	CcSEcCtD
Magnesium salicylate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000478	0.00364	CcSEcCtD
Magnesium salicylate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000478	0.00363	CcSEcCtD
Magnesium salicylate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000477	0.00362	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000477	0.00362	CcSEcCtD
Magnesium salicylate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000476	0.00362	CcSEcCtD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000473	0.0153	CbGpPWpGaD
Magnesium salicylate—PTGS1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000468	0.0152	CbGpPWpGaD
Magnesium salicylate—Carbamazepine—CYP1A2—chronic obstructive pulmonary disease	0.00046	0.182	CrCbGaD
Magnesium salicylate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00046	0.00349	CcSEcCtD
Magnesium salicylate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000451	0.00343	CcSEcCtD
Magnesium salicylate—ALB—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.00044	0.0142	CbGpPWpGaD
Magnesium salicylate—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000434	0.014	CbGpPWpGaD
Magnesium salicylate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000433	0.0033	CcSEcCtD
Magnesium salicylate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000433	0.0033	CcSEcCtD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000432	0.014	CbGpPWpGaD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000426	0.0138	CbGpPWpGaD
Magnesium salicylate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000425	0.00323	CcSEcCtD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	0.000424	0.0137	CbGpPWpGaD
Magnesium salicylate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00319	CcSEcCtD
Magnesium salicylate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00319	CcSEcCtD
Magnesium salicylate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00312	CcSEcCtD
Magnesium salicylate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00311	CcSEcCtD
Magnesium salicylate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000407	0.00309	CcSEcCtD
Magnesium salicylate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000405	0.00308	CcSEcCtD
Magnesium salicylate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.00308	CcSEcCtD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000398	0.0129	CbGpPWpGaD
Magnesium salicylate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000397	0.00302	CcSEcCtD
Magnesium salicylate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00301	CcSEcCtD
Magnesium salicylate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.00296	CcSEcCtD
Magnesium salicylate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00039	0.00296	CcSEcCtD
Magnesium salicylate—Oxcarbazepine—ALB—chronic obstructive pulmonary disease	0.00039	0.154	CrCbGaD
Magnesium salicylate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00294	CcSEcCtD
Magnesium salicylate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00294	CcSEcCtD
Magnesium salicylate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00293	CcSEcCtD
Magnesium salicylate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00293	CcSEcCtD
Magnesium salicylate—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000386	0.00293	CcSEcCtD
Magnesium salicylate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00292	CcSEcCtD
Magnesium salicylate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00292	CcSEcCtD
Magnesium salicylate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.00291	CcSEcCtD
Magnesium salicylate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000382	0.0029	CcSEcCtD
Magnesium salicylate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000378	0.00288	CcSEcCtD
Magnesium salicylate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000378	0.00287	CcSEcCtD
Magnesium salicylate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000376	0.00286	CcSEcCtD
Magnesium salicylate—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000372	0.012	CbGpPWpGaD
Magnesium salicylate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.0028	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000365	0.0118	CbGpPWpGaD
Magnesium salicylate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00277	CcSEcCtD
Magnesium salicylate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00277	CcSEcCtD
Magnesium salicylate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00277	CcSEcCtD
Magnesium salicylate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00277	CcSEcCtD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	0.000363	0.0117	CbGpPWpGaD
Magnesium salicylate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00275	CcSEcCtD
Magnesium salicylate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00271	CcSEcCtD
Magnesium salicylate—ALB—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000349	0.0113	CbGpPWpGaD
Magnesium salicylate—Salicylic acid—ALB—chronic obstructive pulmonary disease	0.000346	0.137	CrCbGaD
Magnesium salicylate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00261	CcSEcCtD
Magnesium salicylate—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00034	0.011	CbGpPWpGaD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000338	0.0109	CbGpPWpGaD
Magnesium salicylate—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000338	0.00257	CcSEcCtD
Magnesium salicylate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000332	0.00252	CcSEcCtD
Magnesium salicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000328	0.0106	CbGpPWpGaD
Magnesium salicylate—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.00248	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.00244	CcSEcCtD
Magnesium salicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000315	0.0102	CbGpPWpGaD
Magnesium salicylate—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000315	0.00239	CcSEcCtD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000301	0.00973	CbGpPWpGaD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000296	0.00958	CbGpPWpGaD
Magnesium salicylate—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000295	0.00225	CcSEcCtD
Magnesium salicylate—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.000295	0.00955	CbGpPWpGaD
Magnesium salicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000291	0.0094	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.00029	0.00937	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000289	0.00934	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000288	0.00932	CbGpPWpGaD
Magnesium salicylate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000284	0.00216	CcSEcCtD
Magnesium salicylate—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000275	0.00888	CbGpPWpGaD
Magnesium salicylate—Ketoprofen—ALB—chronic obstructive pulmonary disease	0.000274	0.109	CrCbGaD
Magnesium salicylate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000273	0.00208	CcSEcCtD
Magnesium salicylate—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00027	0.00874	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000269	0.00869	CbGpPWpGaD
Magnesium salicylate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.002	CcSEcCtD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000256	0.00828	CbGpPWpGaD
Magnesium salicylate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000241	0.00183	CcSEcCtD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000239	0.00773	CbGpPWpGaD
Magnesium salicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000238	0.00771	CbGpPWpGaD
Magnesium salicylate—Shock—Prednisone—chronic obstructive pulmonary disease	0.000237	0.0018	CcSEcCtD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000235	0.00761	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000235	0.00758	CbGpPWpGaD
Magnesium salicylate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000233	0.00177	CcSEcCtD
Magnesium salicylate—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000233	0.00753	CbGpPWpGaD
Magnesium salicylate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00023	0.00175	CcSEcCtD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000222	0.00718	CbGpPWpGaD
Magnesium salicylate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.00167	CcSEcCtD
Magnesium salicylate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00161	CcSEcCtD
Magnesium salicylate—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00021	0.00679	CbGpPWpGaD
Magnesium salicylate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00021	0.00159	CcSEcCtD
Magnesium salicylate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00159	CcSEcCtD
Magnesium salicylate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00159	CcSEcCtD
Magnesium salicylate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.00158	CcSEcCtD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000207	0.00671	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000207	0.00671	CbGpPWpGaD
Magnesium salicylate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00157	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00151	CcSEcCtD
Magnesium salicylate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.0015	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000192	0.00621	CbGpPWpGaD
Magnesium salicylate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00146	CcSEcCtD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000191	0.00617	CbGpPWpGaD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.00019	0.00614	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000188	0.00609	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000174	0.00564	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000171	0.00554	CbGpPWpGaD
Magnesium salicylate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000171	0.0013	CcSEcCtD
Magnesium salicylate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00125	CcSEcCtD
Magnesium salicylate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00121	CcSEcCtD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000156	0.00504	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000155	0.00502	CbGpPWpGaD
Magnesium salicylate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00117	CcSEcCtD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000153	0.00494	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000152	0.00493	CbGpPWpGaD
Magnesium salicylate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00116	CcSEcCtD
Magnesium salicylate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00115	CcSEcCtD
Magnesium salicylate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00115	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000147	0.00477	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000147	0.00477	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000147	0.00476	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000147	0.00474	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000145	0.0047	CbGpPWpGaD
Magnesium salicylate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00109	CcSEcCtD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000135	0.00438	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000134	0.00432	CbGpPWpGaD
Magnesium salicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000127	0.00411	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.0041	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000123	0.00399	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000122	0.00396	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000122	0.00394	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.00012	0.00387	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000119	0.00386	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000119	0.00385	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.000119	0.00385	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000118	0.00382	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000117	0.00379	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000117	0.00379	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000117	0.00378	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000116	0.00375	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000116	0.00374	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.00011	0.00356	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000108	0.00351	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000107	0.00346	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000103	0.00334	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000102	0.00331	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000102	0.0033	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	9.74e-05	0.00315	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	9.69e-05	0.00313	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	9.51e-05	0.00308	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	9.47e-05	0.00306	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.47e-05	0.00306	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	8.69e-05	0.00281	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	8.64e-05	0.00279	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	8.09e-05	0.00262	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	7.84e-05	0.00254	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	7.7e-05	0.00249	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	7.52e-05	0.00243	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.27e-05	0.00235	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	7.09e-05	0.00229	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	7.03e-05	0.00227	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	7.03e-05	0.00227	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	7.02e-05	0.00227	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	6.97e-05	0.00225	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	6.9e-05	0.00223	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.75e-05	0.00218	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	6.7e-05	0.00217	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.7e-05	0.00217	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	6.57e-05	0.00212	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	6.55e-05	0.00212	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	6.45e-05	0.00209	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	6.2e-05	0.002	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	6.15e-05	0.00199	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	6.14e-05	0.00199	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.11e-05	0.00197	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	5.85e-05	0.00189	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.77e-05	0.00187	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	5.73e-05	0.00185	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	5.67e-05	0.00183	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	5.58e-05	0.00181	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	5.57e-05	0.0018	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	5.46e-05	0.00177	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.36e-05	0.00173	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	5.33e-05	0.00172	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.32e-05	0.00172	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	5.21e-05	0.00169	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.86e-05	0.00157	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.85e-05	0.00157	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	4.81e-05	0.00156	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	4.78e-05	0.00154	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.67e-05	0.00151	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	4.53e-05	0.00147	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.51e-05	0.00146	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	4.4e-05	0.00142	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.34e-05	0.0014	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.33e-05	0.0014	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	4.31e-05	0.00139	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.3e-05	0.00139	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GC—chronic obstructive pulmonary disease	4.22e-05	0.00136	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.98e-05	0.00129	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.92e-05	0.00127	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.9e-05	0.00126	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.86e-05	0.00125	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.71e-05	0.0012	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.59e-05	0.00116	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.55e-05	0.00115	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.36e-05	0.00109	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.31e-05	0.00107	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.27e-05	0.00106	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.24e-05	0.00105	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.12e-05	0.00101	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	3.12e-05	0.00101	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	3.08e-05	0.000996	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	3.02e-05	0.000977	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.98e-05	0.000964	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.86e-05	0.000926	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	2.86e-05	0.000924	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.85e-05	0.000921	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.82e-05	0.000911	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.78e-05	0.000898	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KL—chronic obstructive pulmonary disease	2.66e-05	0.000859	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.63e-05	0.000849	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.57e-05	0.000831	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.49e-05	0.000804	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.45e-05	0.000793	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.37e-05	0.000766	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.34e-05	0.000756	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.3e-05	0.000745	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.29e-05	0.000739	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	2.28e-05	0.000737	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.23e-05	0.000722	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.17e-05	0.000701	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	2.08e-05	0.000672	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	1.99e-05	0.000644	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.97e-05	0.000638	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.95e-05	0.00063	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.92e-05	0.000619	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.81e-05	0.000587	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.72e-05	0.000556	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	1.66e-05	0.000537	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.61e-05	0.00052	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.6e-05	0.000517	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.58e-05	0.000509	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.48e-05	0.000477	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	1.47e-05	0.000476	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.47e-05	0.000475	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.41e-05	0.000456	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	1.4e-05	0.000452	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.39e-05	0.00045	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	1.34e-05	0.000432	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	1.21e-05	0.000393	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	1.17e-05	0.000378	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.12e-05	0.000362	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	9.05e-06	0.000293	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	8.83e-06	0.000286	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	8.66e-06	0.00028	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	6.65e-06	0.000215	CbGpPWpGaD
